Mount Sinai Hospital recently announced that a new state of the art care center for patients of all ages living with inflammatory bowel disease (IBD) is now open. The Center features personalized treatments, new strategies in disease management and the chance to participate in clinical trials of the latest treatments.
IBD, which affects around 1.4 million people in the United States alone, is caused by inflammation of the colon and small intestine and comprises two major types: Crohn’s disease and ulcerative colitis. Crohn’s disease was named for Mount Sinai physician Burrill B. Crohn, MD, after he and his colleagues first described the condition in 1932.
The Center is located at 17 East 102nd Street in Manhattan, where a team of gastroenterologists, along with surgeons, pathologists, nurses, social workers, researchers, nutritionists and other allied health professionals will provide children and adults with comprehensive care under one roof.